Biologics News

Bacterin International Holdings Inc. has announced that the company has received patent from the U.S. Patent and Trademark Office for a method to produce a demineralized cancellous bone matrix, such as Bacterin’s OsteoSponge product line.

Bacterin International Holdings Inc. has entered a partnership with DMP Spine Biologics with intent to distribute Bacterin’s biologics products in the European Union.

PHILADELPHIA — T2 mapping and other investigations that researchers at the University of California San Francisco performed show that, among astronauts who go into space, increased hydration up to about 13% occurs in some, but not all of the intervertebral discs.

With few — but encouraging — human clinical studies, researchers remain cautiously optimistic about the use of cell therapy in orthopedics.

Researchers from Malmö University in Sweden found that a decrease in the need for joint surgery among patients with rheumatoid arthritis seen at a later time period in their study may be related to the increased use of pharmacological agents, such as biologics, according to results presented at the American College of Rheumatology Annual Meeting in San Diego.

Total shoulder arthroplasty is a reliable treatment for glenohumeral arthritis in older patients, but the treatment of large, bipolar chondral defects of the shoulder in young patients remains a challenge for even experienced shoulder surgeons. Shoulder arthritis in young patients may be caused by trauma, infection, avascular necrosis, chondrolysis, inflammatory arthritis or early-onset osteoarthritis. These young patients often have high demands and high expectations following surgery, which may lead to issues with patient satisfaction despite excellent technical results. Traditional shoulder arthroplasty would be expected to fail during a young patient’s lifetime due to component wear or loosening, and that has caused us to focus on biologic solutions to this challenging problem.

Bovine thrombin slightly reduced blood loss after total knee arthroplasty in this randomized clinical trial, but researchers noted it was not cost effective enough to warrant routine use.

Researchers of a recently published meta-analysis have concluded that intra-articular injections of hyaluronic acid for the treatment of knee osteoarthritis significantly improve pain and function compared to placebo.

Advanced Biologics has expanded and moved its company headquarters to Carlsbad, Calif.

Invibio Biomaterial Solutions has released its PEEK-OPTIMA HA Enhanced Polymer.